Maybe, just maybe, the end of restrictive federal law on cannabis might be imminent.
At least, that's what President Trump seemed to indicate that day.
Investors caught quite the serious buzz from marijuana stocks on Tuesday, thanks largely to President Trump's strongest indication so far that he will get the ball rolling on the drug's rescheduling. One title that wafted well higher in price was Curaleaf Holdings (OTC: CURLF), which was up by almost 25% when the smoke cleared.
This came in an answer to a reporter's question whether the President would enact an executive order (EO) to direct the government's Justice Department to begin the process of marijuana rescheduling. Justice's Drug Enforcement Administration (DEA) slots drugs into a set of five "schedules," with Schedule I containing what it considers to be the most damaging ones. Marijuana is in this category.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Image source: Getty Images.
Trump stated that he was "considering it, yeah," adding that he and his team were "looking at that very strongly."
It's worth noting that he didn't quite confirm the EO, a subject of speculation over the past few days. But he didn't deny it, either, and media reports indicate that he's in favor of this move toward federal cannabis law reform.
If and when Trump signs off on the EO, and Justice/the DEA puts rescheduling in motion, the fortunes of Curaleaf and its numerous, scattered marijuana industry peers should improve drastically.
At the moment, they're buffeted by a number of negative factors, not least of which is their lack of access to basic financial products and services (technically, after all, weed is illegal on the federal level). Rescheduling, which would be tantamount to de facto legalization, would remove such hurdles and make the entire country one big market for "legitimate" marijuana.
Before you buy stock in Curaleaf, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Curaleaf wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $505,695!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,080,694!*
Now, it’s worth noting Stock Advisor’s total average return is 962% — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of December 16, 2025.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.